Disclosure Nature

Regulatory intimation to BSE Limited regarding upcoming Board of Directors meeting under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Meeting Details

  • Date: Thursday, July 16, 2026
  • Location: Registered Office of the Company
  • Reference: Regulation 29 read with Regulation 33 of SEBI (LODR) Regulations, 2015

Agenda Items

1. Consideration, approval and taking on record of Un-Audited Standalone Financial Results for the quarter ended June 30, 2026 as per Regulation 33 of SEBI (LODR) Regulations, 2015, along with Limited Review Report

2. Consideration and approval of proposal for Reduction of Share Capital of the Company in accordance with applicable provisions of the Companies Act, 2013 and other statutory requirements

  • Subject to approval of shareholders
  • Subject to approval of stock exchange(s)
  • Subject to approval of regulatory authorities
  • Subject to approval of the Hon'ble National Company Law Tribunal (NCLT)

3. Fixing of date, time and venue of General Meeting of the Members of the Company

4. Approval of notice of General Meeting

5. Appointment of Scrutinizer for conducting the E-voting process at the General Meeting

6. Any other matter(s) with the permission of the Chair

Trading Window Closure

In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and Company's Code of Conduct for Prevention of Insider Trading:

  • Trading window closed for all designated persons, connected persons and their immediate relatives
  • Closure period: From Wednesday, July 01, 2026 (as intimated vide letter dated June 30, 2026)
  • Window will open after 48 hours of declaration of results/submission of outcome of the board meeting
  • Closure has been informed to all designated persons covered by the Code

Financial Impact

Financial impact of the proposed share capital reduction not quantified in the disclosure. Impact subject to multiple regulatory and shareholder approvals.

Company Address

UL/8, Ankur Complex, B/h Town Hall, Opp. X-Ray House, Ellisbridge, Ahmedabad, Gujarat, India-380006